Risks to Health Care Workers from Nano-Enabled Medical Products

REFERENCES

• International Organization for Standardization (ISO): Terminology and Definitions for Nano-objects—Nanoparticle, Nanofibre and Nanoplate (ISO/TS 27687:2008). Geneva: ISO, 2008.
   Google Scholar
• Vogel, V., and Baird, B. (Eds.): Nanobiotechnology. Report of the National Nanotechnology Initiative Workshop, October 9–11, 2003. Arlington, VA: NNCO, 2005. . Available at http://www.nano.gov/html/res/pubs.html (accessed December 23, 2014).
   Google Scholar
• Roco, M.C., C.A. Mirkin, and M.C. Hersam, (Eds.): Nanotechnology Research Directions for Societal Needs to 2020: Retrospective and Outlook. NSF, WTEC report. Boston: Springer, 2010. Available at http://www.wtec.org/nano2/Nanotechnology_Research_Directions_to_2020/ (accessed December 23, 2014).
   Google Scholar
• Ramachandran, G., J. Howard, A. Maynard, and M. Philbert: Handling worker and third-party exposures to nanotherapeutics during clinical trials. J. Law, Med., Ethics 40(4):856–864 (2012).
   PubMed Web of Science ®Google Scholar
• Schulte, P.A., C.L. Geraci, V. Murashov, et al.: Occupational safety and health criteria for responsible development of nanotechnology. J. Nanopart. Res. 16:2153–2169 (2014).
   PubMed Web of Science ®Google Scholar
• US Government Accountability Office (GAO): Nanomanufacturing: Emergence and Implications for U.S. Competitiveness, the Environment, and Human Health (GAO-14-181SP). Washington, DC: US Government Accountability Office, January 2014.
   Google Scholar
• Thakor, A.S., and S.S. Gambhir: Nano-oncology: The future of cancer diagnosis and therapy. CA Cancer J. Clin. 63:395–418 (2013).
   PubMed Web of Science ®Google Scholar
• Murashov, V., P. Schulte, and J. Howard: Progression of occupational risk management with advances in nanomaterials. J. Occ. Env. Hyg. 9(1):D12–D22 (2012).
   PubMed Web of Science ®Google Scholar
• Rae, C.S., I.W. Khor, Q. Wang et al. : Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 343(2):224–235 (2005).
   PubMed Web of Science ®Google Scholar
• Chen, Y., Y. Shen, X. Guo, et al.: Transdermal protein delivery by a coadministered peptide identified via phage display. Nature Biotech. 24(4):455–460 (2006).
   PubMed Web of Science ®Google Scholar
• Halo, T.L., K.M. McMahon, N.L. Angeloni, et al.: NanoFlares for the detection, isolation, and culture of live tumor cells from human blood. PNAS 111(48):17104–17109 (2014).
   PubMed Web of Science ®Google Scholar
• “Food and Drugs,” Code of Federal Regulations Title 21, Parts 1 to 1499. 2014.
   Google Scholar
• Mirkin, C.A., A. Nel, and C.S. Thaxton: Applications: Nanobiosystems, Medicine, and Health. In Nanotechnology Research Directions for Societal Needs to 2020: Retrospective and Outlook. NSF, WTEC Report, M.C. Roco, C.A. Mirkin, and M.C. Hersam (eds.). Boston, MA: Springer, 2010. pp. 224–281.
   Google Scholar
• Hogle, L.F.: Science, ethics, and the “problems” of governing nanotechnologies. J. Law Med. Ethics 37(4):749–758 (2009).
   PubMed Web of Science ®Google Scholar
• Marshall, J.: “Draft Guidelines for Nanomedicine Unveiled.” Nature. Published online September 28, 2011. . Available at http://www.nature.com/news/2011/110928/full/news.2011.562.html (accessed December 22, 2014).
   Google Scholar
• Wolf, S.M., and C.M. Jones: Designing oversight for nanomedicine research in human subjects: Systematic analysis of exceptional oversight for emerging technologies. J. Nanopart. Res. 13:1449–1465 (2011).
   PubMed Web of Science ®Google Scholar
• Murashov, V.V., and J. Howard: Essential features of proactive risk management. Nature Nanotech. 4(8):467–470 (2009).
   PubMed Web of Science ®Google Scholar
• Schulte, P.A., C. Geraci, R. Zumwalde, M. Hoover, and E. Kuempel: Occupational risk management of engineered nanoparticles. J. Occup. Env. Hyg. 5(4):239–249 (2008).
   PubMed Web of Science ®Google Scholar
• Pietroiusti, A., and A. Magrini: Engineered nanoparticles at the workplace: Current knowledge about workers’ risk. Occup. Med. 64:319–330 (2014).
   Google Scholar
• US National Science and Technology Council: National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy. National Science and Technology Council, October 2011. . Available at http://nano.gov/sites/default/files/pub_resource/nni_2011_ehs_research_strategy.pdf (accessed December 23, 2014).
   Google Scholar
• Murashov, V.V.: Occupational exposure to nanomedical applications. Wiley Interdisc. Rev.: Nanomed. Nanobiotech. 1(2):203–213 (2009).
   PubMed Web of Science ®Google Scholar
• Methner, M., L. Hodson, and C. Geraci: Nanoparticle Emission Assessment Technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials - Part A. J. Occup. Env. Hyg. 7(3):127–132 (2009).
   Web of Science ®Google Scholar
• Organization for Economic Cooperation and Development (OECD): Emission Assessment for Identification of Sources and Release of Airborne Manufactured Nanomaterials in the Workplace: Compilation of Existing Guidance (ENV/JM/MONO(2009)16). Paris: OECD, 2009.
   Google Scholar
• Schulte, P.A.: The use of biomarkers in surveillance, medical screening, and intervention. Mutat. Res. 592(1–2):155–163 (2005).
   PubMed Web of Science ®Google Scholar
• Iavicoli, I., V. Leso, M. Manno, and P.A. Schulte: Biomarkers of nanomaterial exposure and effect: current status. J. Nanopart. Res. 16:2302 (2014).
   Web of Science ®Google Scholar
• Suspiro, A., and J. Prista: Biomarkers of occupational exposure to anticancer agents: A mini-review. Tox. Lett. 207:42–52 (2011).
   PubMed Web of Science ®Google Scholar
• “Duties of Employers and Employees,” Code of Federal Regulations Title 2929, Part z654. 2010.
   Google Scholar
• “Recording and Reporting Occupational Injuries and Illnesses,” Code of Federal Regulations Title 29, Part 1904. 2011. pp. 43–65.
   Google Scholar
• “Personal Protective Equipment: General Requirements,” Code of Federal Regulations Title 29, Part 1910.132. 2014. pp. 423–424.
   Google Scholar
• “Eye and Face Protection,” Code of Federal Regulations Title 29, Part 1910.133. 2014. pp. 424–426.
   Google Scholar
• “Respiratory Protection,” Code of Federal Regulations Title 29, Part 1910.134. 2014. pp. 426–452.
   Google Scholar
• “Hand Protection,” Code of Federal Regulations Title 29, Part 1910.138. 2014. pp. 461–461.
   Google Scholar
• “Sanitation,” Code of Federal Regulations Title 29, Part 1910.141. 2014. pp. 466–468.
   Google Scholar
• “Cadmium,” Code of Federal Regulations Title 29, Part 1910.1027. 2014. pp. 143–236.
   Google Scholar
• “Hazard Communication,” Code of Federal Regulations Title 29, Part 1910.1200. 2014. pp. 463–591.
   Google Scholar
• US Occupational Safety and Health Administration (OSHA): Letter to Mr. Coe, January 3, 1994. US Occupational Safety and Health Administration, January 1994. . Available athttps://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=21354&p_table=INTERPRE-TATIONS (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): NIOSH List of Antineoplastic and Other Hazardous Drugs In health Care Settings (DHHS (NIOSH) Publication No. 2014-138). Cincinnati, OH: NIOSH, September 2014. . Available at http://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138.pdf (accessed December 23, 2014).
   Google Scholar
• Naumann, B.D., and Sargent, E.V.: Setting occupational exposure limits for pharmaceuticals. Occup. Med.: State of the Art Rev. 12(1):67–80 (1997).
   Web of Science ®Google Scholar
• Sargent, E.V., and G.D. Kirk: Establishing airborne exposure control limits in the pharmaceutical industry. Am. Ind. Hyg. Assoc. J. 49(6):309–313 (1988).
   PubMed Web of Science ®Google Scholar
• Sargent, E.V., B.D. Naumann, D.G. Dolan, E.C. Faria, L. Schulman: The importance of human data in the establishment of occupational exposure limits. Hum. Ecol. Risk Assess. 8(4):805–822 (2002).
   Web of Science ®Google Scholar
• US Occupational Safety and Health Administration (OSHA): Controlling Occupational Exposure to Hazardous Drugs. In OSHA Technical Manual, TED 1-0.15A. Washington, DC: OSHA, January 1999. . Section VI: Chapter 2. Available http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): Workplace Solutions: Medical Surveillance for Health Care Workers Exposed to Hazardous Drugs (DHHS (NIOSH) Publication No. 2013-103). Cincinnati, OH: NIOSH, November 2012. . Available at http://www.cdc.gov/niosh/docs/wp-solutions/2013-103/pdfs/2013-103.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered Nanomaterials (DHHS (NIOSH) Publication No. 2009-125). Cincinnati, OH: NIOSH, March 2009. . Available at http://www.cdc.gov/niosh/docs/2009-125/pdfs/2009-125.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): Current Strategies for Engineering Controls in Nanomaterial Production and Downstream Handling Processes (DHHS (NIOSH) Publication No. 2014-102). Cincinnati, OH: NIOSH, November 2013. . Available at http://www.cdc.gov/niosh/docs/2014-102/pdfs/2014-102.pdf (accessed December 23, 2014).
   Google Scholar
• Safe Work Australia: Engineered Nanomaterials: Evidence on the Effectiveness of Workplace Controls to Prevent Exposure. Commonwealth of Australia, November 2009. Available at http://www.safeworkaustralia.gov.au/ABOUTSAFEWORKAUSTRALIA/WHATWEDO/PUBLI-CATIONS/Pages/RR200911ENEvidenceOnEffectiveness.aspx (access-ed December 23, 2014).
   Google Scholar
• Nyström, A.M., and B. Fadeel: Safety assessment of nanomaterials: Implications for nanomedicine. J. Control Release 161(2):403–408 (2012).
   PubMed Web of Science ®Google Scholar
• “Occupational Exposure to Hazardous Chemicals in Laboratories,” Code of Federal Regulations Title 29, Part 1910.1450. 2014. pp. 591–651.
   Google Scholar
• US Department of Health and Human Services (DHHS): Biosafety in Microbiological and Biomedical Laboratories, 5th ed. (HHS Publication No. (CDC) 21-1112). DHHS, December 2009. . Available at http://www.cdc.gov/biosafety/publications/bmbl5/index.htm (accessed December 23, 2014).
   Google Scholar
• Organization for Economic Cooperation and Development (OECD): Working Party on Manufactured Nanomaterials: Compilation of Nanomaterial Exposure Mitigation Guidelines Relating to Laboratories (ENV/JM/MONO(2010)47). Paris: OECD, 2010.
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): General Safe Practices for Working with Engineered Nanomaterials in Research Laboratories (DHHS (NIOSH) Publication No. 2012-147). Cincinnati, OH: NIOSH, May 2012. . Available at http://www.cdc.gov/niosh/docs/2012-147/pdfs/2012-147.pdf (accessed December 23, 2014).
   Google Scholar
• United Nations Institute for Training and Research (UNITAR): Guidance for Developing a National Nanotechnology Policy and Programme (Pilot Edition 2011). Geneva: UNITAR, 2012. . Available at http://www2.unitar.org/cwm/publications/cw/Nano/UNITAR_nano_gui-dance_Pilot_Edition_2011.pdf (accessed December 23, 2014).
   Google Scholar
• Naumann, B.D., E.V. Sargent, B.S. Starkman, W.J. Fraser, G.T. Becker, G.D. Kirk: Performance-based exposure control limits for pharmaceutically active ingredients. Am. Ind. Hyg. Assoc. J. 57:33–42 (1996).
   PubMed Web of Science ®Google Scholar
• US Bureau of Labor Statistics (BLS): Occupational Employment and Wages—May 2012. US Bureau of Labor Statistics, 2013. Available at http://www.bls.gov/oes/2012/may/oes_stru.htm (accessed December 23, 2014).
   Google Scholar
• International Organization for Standardization (ISO): Occupational Risk Management Applied to Engineered Nanomaterials—Part 2: Use of the Control Banding Approach (ISO/TS 12901-2:2013). Geneva: ISO, 2013.
   Google Scholar
• Polovich, M.: Safe Handling of Hazardous Drugs. Pittsburgh, PA: Oncology Nursing Society, 2003.
   Google Scholar
• US Bureau of Labor Statistics (BLS): Injuries, Illnesses, and Fatalities—2012 BLS, 2014. Available at http://www.bls.gov/iif/oshsum.htm (accessed December 23, 2014).
   Google Scholar
• US Occupational Safety and Health Administration (OSHA): Safety and Health Topics: Health Care. OSHA, 2014. Available at https://www.osha.gov/SLTC/healthcarefacilities/ (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings (DHHS (NIOSH) Publication No. 2004-165). Cincinnati, OH: NIOSH, September 2004. . Available at http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): Workplace Solutions: Personal Protective Equipment for Health Care Workers Who Work with Hazardous Drugs (DHHS (NIOSH) Publication No. 2009-106). Cincinnati, OH: NIOSH, October 2008. . Available at http://www.cdc.gov/niosh/docs/wp-solutions/2009-106/pdfs/2009-106.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): “NIOSH Hazard Review: Occupational Hazards in Home Health Care” (DHHS (NIOSH) Publication No. 2010-125). Cincinnati, OH: NIOSH, January 2010. . Available at http://www.cdc.gov/niosh/docs/2010-125/ (accessed December 23, 2014).
   Google Scholar
• US Occupational Safety and Health Administration (OSHA): Safety and Health Topics: Home Health Care. OSHA, 2014. Available at https://www.osha.gov/SLTC/home_health care/index.html (accessed December 23, 2014).
   Google Scholar
• US Occupational Safety and Health Administration (OSHA): Letter to Ms. Trice, July 22, 1992. OSHA, January 1992. Available at https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=20765 (accessed December 23, 2014).
   Google Scholar
• US Occupational Safety and Health Administration (OSHA): Letter to Ms. Coyne, March 29, 2004. OSHA, 2004. Available at https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=24869 (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): How to Prevent Exposure in Unsafe Conditions (DHHS (NIOSH) Publication No. 2012-121). Cincinnati, OH: NIOSH, February 2012. . Available at http://www.cdc.gov/niosh/docs/2012-121/pdfs/2012-121.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): How to Prevent Driving-Related Injuries (DHHS (NIOSH) Publication No. 2012-122). Cincinnati, OH: NIOSH, February 2012. . Available at http://www.cdc.gov/niosh/docs/2012-122/pdfs/2012-122.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): How to Prevent Needlestick and Sharps Injuries (DHHS (NIOSH) Publication No. 2012-123). Cincinnati, OH: NIOSH, February 2012. . Available at http://www.cdc.gov/niosh/docs/2012-123/pdfs/2012-123.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): How to Prevent Latex Allergies (DHHS (NIOSH) Publication No. 2012-119). Cincinnati, OH: NIOSH, February 2012. . Available at http://www.cdc.gov/niosh/docs/2012-119/pdfs/2012-119.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): How to Prevent Musculoskeletal Disorders (DHHS (NIOSH) Publication No. 2012-120). Cincinnati, OH: NIOSH, February 2012. . Available at http://www.cdc.gov/niosh/docs/2012-120/pdfs/2012-120.pdf (accessed December 23, 2014).
   Google Scholar
• US National Institute for Occupational Safety and Health (NIOSH): How to Prevent Violence on the Job (DHHS (NIOSH) Publication No. 2012-118). Cincinnati, OH: NIOSH, February 2012. . Available at http://www.cdc.gov/niosh/docs/2012-118/pdfs/2012-118.pdf (accessed December 23, 2014).
   Google Scholar
• “Bloodborne Pathogens,” Code of Federal Regulations Title 29, Part 1910.1030. 2010. pp. 265–278.
   Google Scholar
• “Hazardous Waste Operations and Emergency Response,” Code of Federal Regulations Title 29, Part 1910.120. 2009. pp. 368–410.
   Google Scholar
• US Environmental Protection Agency (EPA): Wastes - Non-Hazardous Waste - Industrial Waste. US Environmental Protection Agency, 2014. Available at http://www.epa.gov/osw/nonhaz/industrial/medical/mwfaqs.htm (accessed December 23, 2014).
   Google Scholar
• Maine Department of Environmental Protection: Biomedical Waste. Maine Department of Environmental Protection, 2014. Available at http://www.maine.gov/dep/waste/biomedical/ (accessed Dece-mber 23, 2014).
   Google Scholar
• Organization for Economic Cooperation and Development (OECD): Recycling of Waste Containing Nanomaterials (ENV/EPOC/WPRPW(2013)2). Paris, France: OECD, 2013.
   Google Scholar
• Organization for Economic Cooperation and Development (OECD): Incineration of Waste Containing Nanomaterials (ENV/EPOC/WPRPW(2013)3). Paris, France: OECD, 2013.
   Google Scholar
• Organization for Economic Cooperation and Development (OECD): Compilation of Responses to OECD WPMN SG8 Survey on Disposal and Treatment Technologies for Manufactured Nanomaterials (draft).
   Google Scholar
• Köhler, A.R., C. Som, A. Helland, and F. Gottschalk: Studying the potential release of carbon nanotubes throughout the application life cycle. J. Cleaner Prod. 16(8–9):927–937 (2008).
   Web of Science ®Google Scholar
• Struwe, J., and E. Schindler: Bedeutung von Nanomaterialien beim Recycling von Abfällen, Hans Böckler Stiftung Arbeitspapier AP 270. Düssedorf, Germany: Hans Böckler Stiftung, November 2012.
   Google Scholar
• Association of the German Chemical Industry (VCI): Guidance for the Safe Recovery and Disposal of Wastes containing Nanomaterials. Frankfurt a. M., Germany: VCI, 2012.
   Google Scholar